Insider · CIK 0001836297

Barton Shane

Reports to the SEC for 2 companies · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001836297

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	BIOABioAge Labs, Inc.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+4,290 sh	$10.85	+$46.5K	4,290
2026-06-30	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−7,861 sh	—	—	67,941
2026-06-30	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−4,065 sh	—	—	26,977
2026-06-30	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−4,000 sh	—	—	17,016
2026-06-30	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−4,290 sh	—	—	13,299
2026-06-30	BIOABioAge Labs, Inc.S Sale	Principal Accounting Officer	SSale	−20.2K sh	$25.19	−$509K	0
2026-06-30	BIOABioAge Labs, Inc.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+7,861 sh	$4.38	+$34.4K	20,216
2026-06-30	BIOABioAge Labs, Inc.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+4,065 sh	$4.30	+$17.5K	12,355
2026-06-30	BIOABioAge Labs, Inc.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+4,000 sh	$8.39	+$33.6K	8,290
2026-06-29	BIOABioAge Labs, Inc.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+8,958 sh	$4.30	+$38.5K	28,152
2026-06-29	BIOABioAge Labs, Inc.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+14.2K sh	$4.38	+$62.2K	42,350
2026-06-29	BIOABioAge Labs, Inc.S Sale	Principal Accounting Officer	SSale	−42.4K sh	$25.21	−$1.07M	0
2026-06-29	BIOABioAge Labs, Inc.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+9,301 sh	$10.85	+$101K	11,933
2026-06-29	BIOABioAge Labs, Inc.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+7,261 sh	$8.39	+$60.9K	19,194
2026-06-29	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−14.2K sh	—	—	75,802
2026-06-29	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−8,958 sh	—	—	31,042
2026-06-29	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−7,261 sh	—	—	21,016
2026-06-29	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−9,301 sh	—	—	17,589
2026-02-17	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award	Principal Accounting Officer	AAward	+45K sh	—	—	45,000
2025-02-18	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award	Principal Accounting Officer	AAward	+90K sh	—	—	90,000
2024-12-18	BIOABioAge Labs, Inc. · Stock Option (Right to Buy)A Award	Principal Accounting Officer	AAward	+40K sh	—	—	40,000
2024-09-27	BIOABioAge Labs, Inc.P Purchase	Principal Accounting Officer	PPurchase	+2,632 sh	$18.00	+$47.4K	2,632
2023-06-07	DTILPRECISION BIOSCIENCES INCM Exercise/Conversion	VP & Corporate Controller	MExercise/Conversion	+6,060 sh	—	—	27,502
2023-06-07	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	VP & Corporate Controller	MExercise/Conversion	−6,060 sh	—	—	6,060
2023-03-03	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	VP & Corporate Controller	MExercise/Conversion	−12.7K sh	—	—	25,439
2023-03-03	DTILPRECISION BIOSCIENCES INCM Exercise/Conversion	VP & Corporate Controller	MExercise/Conversion	+12.7K sh	—	—	21,422
2023-01-20	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsA Award	VP & Corporate Controller	AAward	+70K sh	—	—	70,000
2022-06-07	DTILPRECISION BIOSCIENCES INCM Exercise/Conversion	VP & Corporate Controller	MExercise/Conversion	+6,061 sh	—	—	8,720
2022-06-07	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsM Exercise/Conversion	VP & Corporate Controller	MExercise/Conversion	−6,061 sh	—	—	12,120
2022-03-03	DTILPRECISION BIOSCIENCES INC · Employee Stock Option (Right to Buy)A Award	VP & Corporate Controller	AAward	+60.6K sh	—	—	60,604
2022-03-03	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsA Award	VP & Corporate Controller	AAward	+38.2K sh	—	—	38,161
2022-02-28	DTILPRECISION BIOSCIENCES INCA Award	VP & Corporate Controller	AAward	+761 sh	$3.61	+$2,747.21	2,659
2021-08-31	DTILPRECISION BIOSCIENCES INCA Award	VP & Corporate Controller	AAward	+604 sh	$10.68	+$6,450.72	1,898
2021-06-07	DTILPRECISION BIOSCIENCES INC · Employee Stock Option (Right to Buy)A Award	VP & Corporate Controller	AAward	+31.2K sh	—	—	31,242
2021-06-07	DTILPRECISION BIOSCIENCES INC · Restricted Stock UnitsA Award	VP & Corporate Controller	AAward	+18.2K sh	—	—	18,181
2021-02-26	DTILPRECISION BIOSCIENCES INCA Award	VP & Corporate Controller	AAward	+1,294 sh	$4.61	+$5,965.34	1,294

Recent filings

Accepted (ET)
Jul 14
Barton Shane0001836297-26-000005
SEC(opens sec.gov)
Feb 194
Barton Shane0001836297-26-000002
SEC(opens sec.gov)
Mar 104
Barton Shane0001415889-25-007505
SEC(opens sec.gov)

Companies

Address

C/O BIOAGE LABS, INC. 5885 HOLLIS STREET, SUITE 370

EMERYVILLE, CA, 94608